This study was undertaken to observe the changes in coagulation and platelet profile, and findings were correlated with their outcome. Forty consecutive children with severe falciparum malaria were studied for their coagulation status, i.e. prothrombin time (PT), activated thromboplastin time (APTT), thrombin time (TT) and anti-thrombin-III (AT-III), platelet profile (platelet count, platelet aggregation with adenine diphosphate (ADP) and ADR and PF3 availability). Derangements in the coagulation profile in the form of increased PT, APTT and/or TT were seen in 47.5, 35 and 62.5% cases, respectively, but bleeding was seen in only six cases. Thrombocytopenia was found in 34 patients. Platelet aggregation with ADP and ADR revealed hypoaggregation in 95.3 and 97.5% cases, respectively, and were statistically significant. Platelet factor-3 availability was also significantly prolonged. Patients with prolonged PT, PF-3 and hypoaggregation with adrenaline had 1.4, 1.7 and 1.45 times higher risk of mortality.
Background
Malaria is an ancient scourge of humanity. Although almost eradicated from the industrialized nations, malaria continues to extract a heavy toll on life and health in the developing and under-developed countries including India. Children are the worst affected, especially those aged from 6 months to 5 years. Severe malaria causes accelerated turnover of the coagulation cascade, which is a sensitive measure of disease activity [1] [2] [3] .
A variety of hematological alterations like progressively increasing anemia, thrombocytopenia, white blood cell and rarely disseminated intravascular coagulation (DIC) occur in Plasmodium falciparum malaria [4] . Thrombocytopenia is commonly observed in malaria. The reduction in platelet count in malaria is not due to decreased platelet production, but because megakaryocyte number and platelet budding are not adversely affected [4] . Splenic pooling and shortened platelet survival are responsible for the thrombocytopenia. Platelet parasitism may be another possible cause of shortened platelet life span. There may be consumptive thrombocytopenia in cases with concomitant DIC [5] .
The derangement in the coagulation profile in malaria is highly sensitive measure to access the severity and activity of the disease process. There is an accelerated coagulation cascade activity with accelerated fibrinogen turnover, consumption of antithrombin-III (AT-III) and increased concentration of fibrinogen degradation products [6] . Erythrocytes (RBCs) containing parasites and released cytokines are pro-coagulation. Prothrombin time (PT) and activated partial PT (APTT) are prolonged. Severe hemorrhage is reported in 5% of severe malaria [7] . The patient may develop bleeding gums, epistaxis, petechiae, subconjunctival hemorrhages, malena and hemetemesis [3] . This is more common in non-immune individuals in the temperate zone.
There is no such study from this region, which include coagulation status and platelet functions in children with severe malaria. Therefore, this research was conducted to study coagulation status and platelet functions changes and correlate with outcome in children with severe malaria.
Methods

Settings
The present study was carried out in a tertiary care teaching hospital from February 2006 to May 2008.
Institute Postgraduate Board approved the study protocol and informed consent was taken from parent or legal guardian of all patients.
Cases
The study population included children admitted in pediatric ward and pediatric intensive care unit, aged from 1 month to 14 years, having compatible clinical features of malaria (high-grade fever, anemia, splenomegaly, hepatomegaly and altered sensorium), and a positive peripheral smear (thin and thick film) and/ or a positive HRP2 (histidine rich protein 2) antigen detection test were taken in the study.
Controls
Children presenting with abdominal pain without fever were taken as control.
Exclusion criteria
Patients presenting with similar signs and symptoms such as enteric fever, bacterial meningitis and septicemia, but severe malaria was ruled out by peripheral smear and paracheck testing, were excluded.
Patients were subjected to detailed history and physical examination. The definitive diagnosis of malaria was made on the demonstration of the parasites in the blood. The quantitative buffy coat method, HRP2 antigen detection test and peripheral smear testing were carried in all cases.
Examination of the blood film Two types of blood films stained with Leishman's stain were examined-thick blood film (used as a screening for parasites) and thin blood film (used primarily for parasite species identification). Examination of the blood film was based on examination of 200 good fields that is a slide was pronounced negative only, when no parasites were found after examining 200 fields of the blood films. If parasite was found, a further 100 fields were examined before a final identification of species was made.
The collection of blood for coagulation and platelet function study was done prior to start of antimalarial therapy. Nine millilitres of blood was collected by venepuncture through a 22G needle in 3.2% sodium citrate as anticoagulant in a ratio of nine parts of blood to one part of anticoagulant in a plastic tube and transferred to two plastic tubes. The sample was processed within 4 h of blood collection. Platelet-rich plasma (PRP) was made by centrifuging blood at 200g for 10 min and was used for platelet study. Platelet-poor plasma was prepared by centrifugation at 2000g for 10 min and used for coagulation studies, i.e. PT, APTT and thrombin time (TT) by standard techniques manually in a water bath.
Complete blood count including platelet count was done in an autoanalyser using EDTA blood. AT-III studies were done by the method of Innerfield et al. [8] using serum. Platelet factor 3 (PF-3) availability tests was performed in PRP by the method of Hardisty and Hutton [9] , which was based on kaolin-clotting time. Platelet aggregation studies were done on PRP by platelet aggregometry on dual channel chronology aggregometer using ADP in a concentration of 5 mM/l and epinephrine; 2.5 mM/l and percentage of aggregation was measured after 10 min. Bloods samples were sent for electrolytes and renal function tests. Arterial blood gas analysis was done in all patients.
Treatment and monitoring
Patients were treated with either intravenous (IV) quinine dihydrochloride alone (20 mg/kg loading dose infused >4 h in 5% dextrose, followed by 10 mg/kg three times daily) or IV artesunate (2.4 mg/kg bodyweight then at 12 h, 24 h and thereafter once daily) and clindamycin until starting oral medication. Patients with hypotension and hypoglycemia were treated with artesunate and clindamycin. During hospital stay, the patients were monitored for fever, blood glucose, level of consciousness, azotemia, jaundice and DIC.
Statistical analysis
The data were analyzed with SPSS version.10. software. This software was used for basic work tabulation, inferences and associations. Student's t-test was applied to compare means of case and control groups in normally distributed data and Mann-Whitney test was used, where data did not follow Gaussian distribution. Fisher's exact test was used to see the significant risk factor associated with the outcome. Relative risk and 95% confidence interval were also calculated.
Results
Fifty-four children were enrolled in study, but 14 children were eventually excluded. Six children had concomitant enteric fever, four had septicemia and four had bacterial meningitis. Out of the 40 remaining children with severe malaria, 30 were males and 10 were females, in age range 1-15 years (mean age: 7.23 AE 3.01 years). The lowest age of affected child was 2 months. Fever was present in all cases, which was followed by pallor (97.5%), chills (72.5%), unconsciousness (62.5%) and seizures (40%). Less frequent manifestations included oliguria (22.5%) and bleeding (15%). In our study, as per the World Health Organization criteria, maximum number of cases was of severe anemia followed by cerebral malaria presenting either as coma and/or seizures. Hypoglycemia was present in 22.5% children.
Significant bleeding from nose, gums and gastrointestinal tract and/or evidence of DIC was present in 15% cases. Renal failure was present in 22.5% and shock in 10% cases (Table 1) . Basic parameters of cases and controls are mentioned in Table 2 . Hemoglobin, renal functions and electrolytes in cases showed significant difference with control but serum potassium was within normal range.
PT, APTT and/or TT were prolonged in 47.5, 35 and 62.5% cases, respectively, but clinical evidence of bleeding was seen in only six (15%) cases. PT, APTT and TT showed significant prolongation in cases (Table 3) . Though AT-III levels were within normal range in cases, the changes in the AT-III levels were also statistically significant.
Thrombocytopenia was found in 34 (85%) cases of P. falciparum malaria. Mean platelet count was 92 650 AE 43 339.77/mm
À3
. This difference was significant when compared with the control group. Lowest platelet count observed in this study was 20000/mm
. Platelet aggregation studies with agonists such as ADP and adrenaline revealed hypoaggregation in 95.3 and 97.5% cases, respectively. PF-3 availability was also increased in 29 (72.5%) patients. Patients of falciparum malaria had significant decline in platelet count and elevated PF-3 levels (p < 0.001) as compared to control. Platelets of cases had also significant hypoaggregation to ADP and adrenaline (Table 4) .
Twelve (30%) children with faciparum malaria had died. The correlation of coagulation studies (Table 5) among survivors and death in children with severe malaria showed significant correlation with PT (relative risk (RR), 1.4; CI, 0.764-2.56). Patients with prolonged PF-3 had 1.7 times risk of mortality (RR, 1.70) when compared to survivors, whereas patients with hypoaggregation to ADR had 1.45 times higher risk of death (RR, 1.45).
Discussion
In severe malaria, there is increased turnover of the coagulation cascade that results in consumptive coagulopathy, which may lead to development of DIC.The exact mechanism is not known; however, it has been hypothesized that infected erythrocytes possess pro-coagulant activity because of changes in the lipid distribution across the inner and outer surfaces of the infected erythrocyte membrane [10] . Endothelial damage may also be important in promoting activation of the coagulation cascade. Although derangement of the coagulation profile occurs commonly in cases with severe malaria, manifest bleeding occurs in very few cases only as in our study [11] . PT, APTT and TT were prolonged in 47.5, 35 and 62.5% patients, respectively, in the present study. Phillips and Looareesuwan [12] had found abnormal PT in 18.1% cases and APTT in 31.3% cases, whereas AT-III was abnormal in 79.3% cases in patients with severe malaria. The abnormal cutoff value for AT-III taken in this study was lower, i.e. if the activity is <98% of the controls. There was a significant decrease in plasma AT-III concentration (p < 0.001) in present study but levels were within normal range. Rojanasthein and Boonpucknavig [13] had also reported statistically significant difference in the mean PT and APTT, but Pukrittayakamee et al. [1] observed no changes in PT, APTT and TT. However, he reported reduced plasma concentration of AT-III (activity <75%) in adults with severe malaria. The depletion in AT-III activates the coagulation cascade, thereby leading to increased clotting-factor consumption. Thrombocytopenia is also common in severe malaria. The incidence and severity of thrombocytopenia appears to be related to the clinical severity of the infection [14] and has been found to be a poor prognostic indicator in severe malaria [15] . Sharma et al. [16] reported thrombocytopenia in 90% cases, the lowest count being 26 000 mm À3 which was comparable to what we found in our study. Abnormal platelet counts found in present study are also comparable to those reported by other workers [4, 10, 13] .
In addition to thrombocytopenia, defect in the platelet functions is also reported in severe malaria and may contribute to bleeding associated with severe infection [10] . In our study, we have found defective aggregation with ADP in 95.3% and ADR in 97.5%. PF-3 availability studies showed abnormal results in 72.5% cases and showed insignificant differences in present study, but Mohanty et al. [10] observed 8% defective platelet aggregation in response to ADP and ADR. This finding is in contradiction with our study, but can be explained by inclusion of only severe malaria cases in our study.
On correlation of derangement of various parameters with mortality, children with abnormal PT had 1.4 times risk of mortality, whereas patients with abnormal PF-3 availability studies and abnormal aggregation with ADR had 1.7 and 1.4 times risk of mortality as compared with children of severe malaria having normal levels.
Severe malaria causes significant derangement in coagulation, platelet counts and platelet functions in children but clinical bleeding is uncommon. Abnormal PT, PF3 and defective aggregation to adrenaline may be important poor prognostic indicators in severe malaria and monitoring of them may be helpful in management and outcome of such patients.
